{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T20:49:29Z","timestamp":1706993369026},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jocd.2008.02.004","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T18:44:01Z","timestamp":1210099441000},"page":"417-423","source":"Crossref","is-referenced-by-count":5,"title":["Rapid Suppression of Bone Resorption Marker Levels With Ibandronate Therapy in a Bisphosphonate-Na\u00efve Population"],"prefix":"10.1016","volume":"11","author":[{"given":"A.I.","family":"Sebba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Broy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Kohles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2008.02.004_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1185\/030079905X41390","article-title":"How useful are measures of BMD and bone turnover?","volume":"21","author":"Miller","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jocd.2008.02.004_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1210\/jc.76.6.1399","article-title":"The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women","volume":"76","author":"Harris","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2005.12.020","article-title":"Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?","volume":"119","author":"Bonnick","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2008.02.004_bib6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/00003495-200666160-00001","article-title":"Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls","volume":"66","author":"Cremers","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jocd.2008.02.004_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib8","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1210\/jc.2004-1091","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib9","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1210\/jc.85.10.3537","article-title":"Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women","volume":"85","author":"Greenspan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.52.667","article-title":"Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis","volume":"52","author":"Kim","year":"2005","journal-title":"Endocr J"},{"issue":"Suppl 6","key":"10.1016\/j.jocd.2008.02.004_bib11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"issue":"Suppl 6","key":"10.1016\/j.jocd.2008.02.004_bib12","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","article-title":"Markers of bone turnover for the prediction of fracture risk","volume":"11","author":"Garnero","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2008.02.004_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0889-8529(05)70007-4","article-title":"Biochemical markers of bone turnover. Applications for osteoporosis","volume":"27","author":"Garnero","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jocd.2008.02.004_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00228-006-0174-3","article-title":"An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice","volume":"62","author":"Leeming","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jocd.2008.02.004_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.rhu.0000208612.33819.8c","article-title":"Important determinants of bone strength: beyond bone mineral density","volume":"12","author":"Friedman","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jocd.2008.02.004_bib16","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF02938621","article-title":"Monitoring osteoporosis therapies","volume":"5","author":"Miller","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocd.2008.02.004_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","article-title":"Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis","volume":"92","author":"Delmas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.blo.0000200249.12006.6e","article-title":"Long-term outcome of weekly bisphosphonates","volume":"443","author":"Rizzoli","year":"2006","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib20","series-title":"Boniva (ibandronate sodium)","year":"2005"},{"key":"10.1016\/j.jocd.2008.02.004_bib21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study","volume":"15","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2008.02.004_bib22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2005.044958","article-title":"Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2-year results from the MOBILE study","volume":"65","author":"Reginster","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2008.02.004_bib24","first-page":"S94","article-title":"Results of a three-month randomized trial to examine week-by-week effects of monthly ibandronate on biochemical markers of bone resorption","volume":"17","author":"Kung","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2008.02.004_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocd.2008.02.004_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1359\/jbmr.1999.14.4.609","article-title":"Changes in bone resorption during the menstrual cycle","volume":"14","author":"Chiu","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.02.004_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00298428","article-title":"Urinary biochemical markers for bone resorption during the menstrual cycle","volume":"57","author":"Gorai","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2008.02.004_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jc.83.2.326","article-title":"Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle","volume":"83","author":"Gorai","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1210\/jcem-70-5-1431","article-title":"Changes in biochemical markers of osteoblastic activity during the menstrual cycle","volume":"70","author":"Nielsen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2008.02.004_bib30","unstructured":"Derman RJ, Kohles JD, Gass ML. 2007 Physiological pattern of sCTX in relation to the menstrual cycle of healthy women. Paper presented at: International Society for Clinical Densitometry; Tampa, FL; March 14\u201317, 2007."}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695008000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695008000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T09:17:45Z","timestamp":1588670265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695008000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1094695008000334"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2008.02.004","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}